Ranibizumab Intraocular and Valproic Acid and Derivatives
Determining the interaction of Ranibizumab Intraocular and Valproic Acid and Derivatives and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: valproic acid
Brand name: Depakene, Depacon, Stavzor, Valproate Sodium
Synonyms: Valproic acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Valproic Acid Capsules
- Ranibizumab Intraocular-Valproic Acid Liquid
- Ranibizumab Intraocular-Valproic Acid Oral Solution
- Ranibizumab Intraocular-Valproic Acid Syrup
- Ranibizumab Intraocular-Valrubicin
- Ranibizumab Intraocular-Valrubicin Intravesical
- Valproic Acid and Derivatives-Ranibizumab ophthalmic
- Valproic Acid and Derivatives-Ranitidine
- Valproic Acid and Derivatives-Ranitidine Capsule
- Valproic Acid and Derivatives-Ranitidine Hydrochloride
- Valproic Acid and Derivatives-Ranitidine Injection
- Valproic Acid and Derivatives-Ranitidine Suspension